Picture a world where most life-saving medicines are discovered not in the United States, but in Beijing and Shanghai. Imagine a time when the most advanced biotechnologies, therapies that cure ...

Finance Income, net, was $0.1 million for the three months ended September 30, 2025, compared to $1.5 million in the same ...

Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and ...

The Novo Nordisk Foundation in Denmark, one of the world’s leading funders of pharmaceutical and biotechnology research, is investing €21.7 million to support emerging and rising Danish researchers in ...

Sanyou Bio and Yugong Biotoday announced the signing of a strategic cooperation agreement. This powerful alliance marks a significant step to deepen their collaboration in the development of high-end ...

OpenAI has committed to spending $1.15 trillion (updated to $1.4 trillion) on hardware & cloud infrastructure between 2025 & ...

With funding at a constant risk of revocation, Harvard is not out of the clear — and researchers are still fighting for their ...

Agriculture and natural resources major Daisy Creel immerses herself in animal and food science, agribusiness and policy ...

Reached agreement with FDA on pivotal study design for TSC-101 following productive end of Phase 1 meetingData from ALLOHA™ Phase 1 heme trial to ...

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today ...

All of these questions deserve urgent exploration. Unfortunately, the discovery comes at a particularly difficult moment for ...

Presented new data at the Society of Immunotherapy for Cancer (SITC) annual meeting on CLD-401 protection from immune clearance after systemic administration; data also demonstrates that the platform ...